Search Results

Search

Ethics Talk: Antibiotic Stewardship During COVID

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Olivia Kates about appropriate use of antibiotics during the COVID-19 pandemic.

Click here to read the transcript.

Olivia Kates, MD is a third-year fellow in infectious diseases at the University of Washington in Seattle. 

Video

Recorded on May 17, 2021

Infectious Disease Medical Knowledge Patient Care

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Ending the HIV Epidemic Off

Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

 

Neurology Patient Care

Audio

 

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Visibility and Measurability in Health Care Off
Viewpoint
Jun 2008

Medical Care for the Elderly: Should Limits Be Set? Commentary 1

Daniel Callahan, PhD
Should old folks who have lived their lives be allowed to place a huge economic burden on the young by using a disproportionate amount of limited Medicare resources for medical care?
Virtual Mentor. 2008; 10(6):404-407. doi: 10.1001/virtualmentor.2008.10.6.oped1-0806.
Case and Commentary
Dec 2008

Role of Schools in Monitoring Student Health

Benjamin Caballero, MD, PhD
This case poses two important questions. First, do schools have the right or the duty to monitor students’ health status measures and require action from parents and, second, what is the role of a student’s primary care physician in this context?
Virtual Mentor. 2008; 9(12):790-793. doi: 10.1001/virtualmentor.2007.9.12.ccas1-0712.
Policy Forum
Dec 2007

Mandatory Reporting of Noncommunicable Diseases: The Example of The New York City A1c Registry (NYCAR)

Clarissa G. Barnes, Frederick L. Brancati, MD, MHS, and Tiffany L. Gary, PhD, MHS
To combat the rising incidence of type 2 diabetes, New York City requires laboratories with electronic reporting capacity to upload data on hemoglobin A1c measurements to a city department of health registry.
Virtual Mentor. 2007; 9(12):827-831. doi: 10.1001/virtualmentor.2007.9.12.pfor2-0712.
Case and Commentary
Jan 2019

Should Immigration Status Information Be Considered Protected Health Information?

Scott J. Schweikart, JD, MBE
Being undocumented is a risk factor for mental illness, and immigration status relates prominently to overall health. That’s enough to consider it protected health information under the Health Insurance Portability and Accountability Act Privacy Rule.
AMA J Ethics. 2019; 21(1):E32-37. doi: 10.1001/amajethics.2019.32.
Medicine and Society
Apr 2022

How Should Representation of Subjects With LEP Become More Equitable in Clinical Trials?

Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022; 24(4):E319-325. doi: 10.1001/amajethics.2022.319.